Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Issaka Seidou"'
1
Akademický článek
Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA Extraction.
Autor: Jeni Vuong, Jean-Marc Collard, Melissa J Whaley, Issaka Bassira, Issaka Seidou, Seydou Diarra, Rasmata T Ouédraogo, Dinanibè Kambiré, Thomas H Taylor, Claudio Sacchi, Leonard W Mayer, Xin Wang
Publikováno v: PLoS ONE, Vol 11, Iss 2, p e0147765 (2016)
Neisseria meningitidis (Nm), Haemophilus influenzae (Hi), and Streptococcus pneumoniae (Sp) are the lead causes of bacterial meningitis. Detection of these pathogens from clinical specimens using traditional real-time PCR (rt-PCR) requires DNA extrac
Externí odkaz: https://doaj.org/article/08c5d1185e3f42b99c069b14c3433a9a
Zobrazit plný text záznamu
2
Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010–2018
Autor: Bassira Issaka, Issaka Seidou, Jennifer L. Farrar, Miwako Kobayashi, Sable Sharpley, Cynthia G. Whitney, Mahamoudou Ouattara, Sani Ousmane
Publikováno v: Vaccine. 38:3922-3929
Pneumococcal meningitis in the African meningitis belt is primarily caused by Streptococcus pneumoniae serotype 1, a serotype contained in the 13-valent pneumococcal conjugate vaccine (PCV13). In 2014, Niger introduced PCV13 with doses given at 6, 10
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9258ef14f8247580179bf7eb4449e76
https://doi.org/10.1016/j.vaccine.2020.04.009
Zobrazit plný text záznamu
3
Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010–2018
Autor: Djibo Issifou, Jean Testa, Xin Wang, Souleymane Sakande, Ali Sidiki, Amadou Moussa, Maman Zaneidou, Sani Ousmane, Ricardo Obama Nse, Issaka Seidou, Goumbi Kadadé, Clement Lingani, Caelin C. Potts, Bassira Issaka, Omar Garba, How-Yi Chang, Ali E. Mahamane, Moussa Abdou, Alpha Oumar Diallo, Sani Haladou, Sarah Mbaeyi, Fati Sidikou, Alexander Chen, Baruani Bienvenu, Halima Boubacar Maïnassara, Marietou F Paye
Publikováno v: Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2019, 220 (Supplement_4), pp.S206-S215. ⟨10.1093/infdis/jiz296⟩
Journal of Infectious Diseases, 2019, 220 (Supplement_4), pp.S206-S215. ⟨10.1093/infdis/jiz296⟩
J Infect Dis
Background In 2010, Niger and other meningitis belt countries introduced a meningococcal serogroup A conjugate vaccine (MACV). We describe the epidemiology of bacterial meningitis in Niger from 2010 to 2018. Methods Suspected and confirmed meningitis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b84be88eab3619cafb8032869e747821
https://hal.archives-ouvertes.fr/hal-02881969
Zobrazit plný text záznamu
4
Antibiotic Resistance Mechanisms Focusing on Quinolones Resistance in Vibrio CHOLERAE
Autor: Jibir Zanguina, Issaka Seidou, Bassira Issaka, Lawaly Maman Manzo
Publikováno v: International Journal of Infection. 4
Context: The number of quinolone-resistant Vibrio cholerae strains reported in various clinical studies is growing steadily since the 1990s. Important biological conditions such as alterations of DNA topoisomerases, perturbations in regard to drug en
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7472d72639ee37a2a92e2c316ca92c00
https://doi.org/10.5812/iji.40622
Zobrazit plný text záznamu
6
Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data
Autor: Goumbi Kadadé, Jibir Zanguina, Didier Mounkoro, Olivier Ronveaux, Sarah A. Meyer, Souleymane Sakande, Clement Lingani, Maman Zaneidou, Assimawe Pana, Jean Paul Moulia-Pelat, Fati Sidikou, Xin Wang, Ricardo Obama, Bassira Issaka, Stephanie Schwartz, Oubote Abodji, Odile Ouwe Missi Oukem-Boyer, Ryan T. Novak, Sani Ousmane, Flavien Ake, Innocent Nzeyimana, Ashley H. Tate, Ibrahim Alkassoum, Muhamed-Kheir Taha, Issaka Seidou
Publikováno v: The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2016, ⟨10.1016/S1473-3099(16)30253-5⟩
The Lancet Infectious Diseases, 2016, ⟨10.1016/S1473-3099(16)30253-5⟩
Summary Background To combat Neisseria meningitidis serogroup A epidemics in the meningitis belt of sub-Saharan Africa, a meningococcal serogroup A conjugate vaccine (MACV) has been progressively rolled out since 2010. We report the first meningitis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fede582bc2867e46109c31d20be84a81
https://europepmc.org/articles/PMC5737706/
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje